CClinicalTrials.gg
TerminatedNCT02294812Updated Jan 27, 2021

Effects of Cognitive Training on Speech Perception

An interventional study of Cognitive training in Hearing Loss and Deafness and Auditory Perception, sponsored by Aaron Newman. Terminated at 1 site in Canada. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2021-01-27.

Sponsored by Aaron Newman · Not applicable, Interventional, and Treatment

Why this study was terminated
lack of funding and staff to conduct the study
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

In this study, the investigators are testing whether cognitive training can lead to improvements in speech perception for individuals with hearing loss. Individuals will complete 20 hours of cognitive training that is designed to improve cognitive abilities such as short term memory and attention. The investigators predict that cognitive training that improves the cognitive abilities affected by hearing loss will improve speech perception.

02

Conditions studied

  • Hearing Loss
  • Deafness and Auditory Perception

Keywords

  • Hearing Loss
  • Speech Perception
  • Cognitive Training
  • Cognitive Fitness
  • Memory, Short-Term
03

In context

Hearing Loss

1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.

This study's enrollment of 42 is close to the median of 40 across 764 interventional studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

Aaron Newman is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Able to come to Dalhousie University, Halifax, Nova Scotia, Canada for study visits
  • Adults (50 years or older) with mild to moderate hearing loss
  • Access to an internet-connected device that is able to use Flash media, basic computer skills
  • Medically stable participants
  • Not currently taking medication that may affect brain function (e.g., anti-anxiety medication)
  • Normal or corrected-to-normal vision

Exclusion criteria

Exclusion Criteria:

  • Participants with neurological conditions such as epilepsy or concussions will be excluded for safety reasons
  • Participants who are not native English speakers (materials used in the study are only in English)
  • Participants who are unable to provide consent
  • Participants with impaired cognition (assessed with the Montreal Cognitive Assessment)
  • Participants with high accuracy on the Speech Perception in Noise task at the second study visit (to eliminate participants who may be performing at ceiling level)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
42 participants (actual)

Study arms

  • Active comparator
    Control, cognitive training

    Participants in the control arm will receive cognitive training for cognitive abilities not affected by age-related hearing loss.

    Behavioral: Cognitive training

  • Experimental
    Experimental, cognitive training

    Participants in the experimental arm will receive cognitive training for cognitive abilities affected by age-related hearing loss.

    Behavioral: Cognitive training

  • Active comparator
    Active Control, crossword training

    Participants in this group will undergo crossword puzzle training. The purpose of this group is control for any effects that may be due to engaging in cognitive training.

    Behavioral: Cognitive training

Interventions

  • BehavioralCognitive training

    Participants will engage in eight weeks of training that focuses on improving various cognitive abilities. For example, short term memory. Cognitive training will take place 30 minutes per day, five days per week, for eight weeks. Training will be done in the participant's own home using web-based software. Participants will be randomly assigned to either the active control group, the control cognitive training group, or the experimental cognitive training group following the second study visit. After eight weeks, participants will no longer partake in training.

06

What researchers measure

Primary outcomes

  1. Speech Perception in Noise Test - Improvement in speech perception accuracy from baseline to post-training for high and low predictability sentences

    Sentences of high predictability and low predictability are played with multi-user talker babble. Participants must repeat the last word of each sentence as they heard it. The primary outcome measure will be the accuracy for repeating the sentence.

    Time frame: Baseline, Weeks 2, 10, and 18

Secondary outcomes

  1. Working Memory Cognitive Training - Improvements in working memory abilities from baseline

    Individuals are asked to participate in 20 hours of cognitive training that will focus on either improving abilities affected by hearing loss (i.e., verbal working memory), or abilities not affected by hearing loss (i.e., spatial working memory). Performance on the working memory task, Operation Span Task (OSPAN), will be assessed using the total score which is calculated as a sum based on the number of correct answers (letters accurately sequentially recalled) within a block for the duration of the task. Higher scores indicate better working memory capacity. Performance on the working memory cognitive training games will be assessed using the participant's accuracy, reaction time, and final score on the game. Improvements in working memory will be assessed by comparing participant performance on working memory tasks (OSPAN; cognitive training memory games) before receiving cognitive training, immediately after receiving cognitive training, and eight weeks post-training.

    Time frame: Weeks 2, 10, and 18

  2. Brain Performance Test

    The Brain Performance Test (BPT) is an assessment tool available online through the training program website. Participants will be assessed at home on their initial performance for a variety of cognitive abilities including stop-signal tasks, grammatical reasoning, and memory spans. After completing the eight weeks of cognitive training, participants will again be assessed at home with the BPT to determine whether there are any improvements in cognitive abilities.

    Time frame: Weeks 2 and 10

  3. Attention Cognitive Training - Improvements in attention abilities from baseline

    Individuals are asked to participate in 20 hours of cognitive training. Cognitive training will focus on either improving abilities affected by hearing loss (i.e., attention), or abilities not affected by hearing loss (i.e., spatial working memory). Performance on the attention task, Flanker-Simon, will be assessed based on participant's accuracy and reaction time for the Flanker task, and the Simon task. Performance on the attention cognitive training games will be assessed using the participant's accuracy, reaction time, and final score on the game. Improvements in attention will be assessed by comparing the performance of participants on attention tasks (Flanker-Simon; cognitive training attention games) before receiving cognitive training, immediately after receiving cognitive training, and eight weeks post-training.

    Time frame: Weeks 2, 10, and 18

07

Study locations

1 site
  • NeuroCognitive Imaging Lab, Dalhousie University
    Halifax, Nova Scotia B3H 4R2, Canada
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02294812
Lead sponsor
Aaron Newman
Responsible party
Aaron Newman (Neuropsychologist, Nova Scotia Health Authority) — Sponsor-investigator
First posted
Nov 19, 2014
Start date
Sep 2016
Primary completion
Sep 2020
Completion
Sep 2020
Last update
Jan 27, 2021

Study contacts

Aaron J Newman, PhD
principal investigator · Dalhousie University, Canada

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion